$11 billion biotech binge fuels forecasts of 2018 M&A surge
LONDON (Reuters) - An $11 billion burst of biotech bids in just four days has fueled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.
from Reuters: Health News http://reut.rs/2m9haMR
http://bit.ly/2zwRqiM